mosome G-banding), imaging test (ie, cranial pelvis X-ray, cervical, thoracic, and lumbosacral vertebral magnetic resonance imaging or PET-CT). Subjects with MM, amyloidosis, POEMS, and lymphoma were excluded. Once subjects were diagnosed as MGUS, they were followed up and examined with blood and urine tests once every 3 months as well as bone marrow puncture once every year. Subsequent follow-up duration could be extended to 6 months if the M protein was unchanged within 1 year (ie, 10%). If the disease progression was identified in subjects, it should be registered and reported. Imaging examinations were conducted if necessary based on the decision of researchers.
The serum protein electrophoresis was conducted with Sebia Capillarys 2 electrophoresis apparatus. Urine immunofixation electrophoresis (IFE) was conducted through fully automatic agarose gel electrophoresis apparatus (Sebia Hydrasys 2 electrophoresis apparatus, French Sebia company), using five kinds of antiserum for serum IFE Figure 2 ).
| Bone marrow
Data from a total of 49 cases that were collected showed that the average of bone marrow plasmacyte were 3.4%. Forty-one cases received the chromosome G-banding, and five cases (12.2%) were abnormal, which were 45 (X, −Y); t (6;11) (p11;q23); t (7;11); 47, The number was presented as number/total number (%).
XXX; 47, XX, +2, respectively. The FISH was done in 35 patients, the positive rate was 22.8% (eight cases), including five cases were IgH rearrangement, one case was 1 q21 amplification, two cases were RB1 deletion and D13S319 deletion (7.5%). In which of the five cases, only one case continued to be done IgH translocations including t (11;14), t (4;14), t (14;16), and was found t (11;14) . Real-time quantitative PCR was used to detect the MAGE-C1/CT7 gene (reference gene ABL) in 28 patients, the positive rate was 78.6% (median: 0.37%, range: 0.01 to 24.69%).
| Follow-up
The M protein of one case became negative after 3 months, and the others remained positive without obvious disease transformation (follow-up duration: 3-7 mo).
| DISCUSSION
Patients with MGUS were always asymptomatic, and the majority of patients were identified with the change of immunoglobulin at annual physical examination or visit due to other illnesses and then diagnosed based on serum protein electrophoresis, serum immunofixation electrophoresis, and free light chain. Since the false dismissal rate was high, MGUS can be easily ignored by the clinicians. Therefore, the actual rate of MGUS was much higher than the data. most of the subtypes were IgG, but the age of their studying object was 50 to 65 years; it was not comparable with the other previous studies. Our study showed that on the Chinese mainland, the prevalence of MGUS over the age of 50 was 3.08%, and the data in the group of 41 to 50 years was 1.19%. The data were higher than that in Japan and
South Korea, 18 which may be associated with the different detection method. As the positive rate of MGUS by capillary electrophoresis was nearly twice than by agarose gel electrophoresis, 19 the prevalence in
China was similar to that in Mexican Americans, but lower than that in the other Asian country (Japan 2.1%, Thailand 2.3%), American whites(2.33%), American blacks(3.67%), and Africans(5.84%).
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The positive rate was different by different detection methods. In a large study in Olmsted County, Kyle and his colleagues analyzed more than 75% of residents (50 y or older), using agarose gel electrophoresis test, and identified 3.2% of subjects with MGUS. There was a significant age-dependent increase with the prevalence among persons aged 70 years or older (up to 5.3%). 7 Subsequently, Dispenzieri and his colleagues used the free light-chain assay on a majority of the same people and showed a higher prevalence of MGUS in people aged more than 50 (4.2%). 8 An Italian study 19 by means of capillary electrophoresis showed that the prevalence of MGUS increased from 3.2% to 6%, which nearly doubled than that previous report. Our study used capillary electrophoresis and found that the prevalence of MGUS over 40 years old was 2.73%, which was lower than that in Italy. This may be related to ethnic differences.
Our data also verified that the men had a higher prevalence (2.97%-2.52%) in China, which was consistent with previous report in the United States (2.8%-2.0%).
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The data from Mayo Clinic showed that the most common subtype of MGUS was IgG (69%), followed by IgM type (17%) and IgA type (11%). 7 However, the IgA type in Korea 18 was the most common subtype (43%), followed by IgG (29%) and IgM (19%). Our data were similar to that of Mayo Clinic, which showed that the most common subtype of IgG was 55.1%, but followed by IgA type (14.3%). Due to the heavy air pollution in China, there may be different types of distribution, such as the IgA type, which was slightly higher than that in
Europe and the United States. The prevalence of IgA nephropathy in
China is significantly higher than that of other countries, which may FIGURE 1 Monoclonal gammopathy of undetermined significance prevalence in patients with different age and gender FIGURE 2 MP types in monoclonal gammopathy of undetermined significance patients in different age groups be related to the environmental pollution. 20 Our study showed that the IgM type was 12.2%, which was lower than that of other countries without significant descending.
There were fewer plasma cells and lower cell proliferation in bone marrow of MGUS; hence, the conventional karyotype analysis was always normal in majority of patients. However, with the emergence of the more sensitive methods, people found that the incidence of chromosomal abnormalities was not uncommon. Bacher et al 21 found
that the abnormality rate of iFISH in 302 patients with MGUS was 56% (median application of 11 probe), among which the incidence of 13q deletion was 22.1%, 17p deletion was 2.2%, and t (11;14), t (4;14), t (14;16) was 18.7%, 1.9%, and 1.1%, respectively. Fonseca et al 22 confirmed that 46% of MGUS had IgH rearrangement. Our data showed that the abnormal rate by the chromosome G-banding was 12.2%, and by the iFISH detection, the abnormal rate increased to 22.8%, including positive rate of IgH rearrangement was 14.2%, lower than that Ulrike had reported, which may be related to the less probes in our center currently (five to eight).
The MAGE-C1/CT7 gene was specific for the malignant plasmacyte diseases. Our center has reported 23 that the positive rate of MAGE-C1/CT7 was 88.5% in the newly diagnosis of MM (median:
443.2%). Our study found that the positive rate in patients with MGUS was 78.6%, but the expression level was 0.37%, lower than that of MM patients.
Most of the patients with MGUS were "asymptomatic," although this could last for a long time and was initially considered as a "benign" developed into malignant disease in each year; 11% of the patients died of MGUS progression. Other studies also found that 12% to 17% of patients had progression at the 10 years of follow-up followed by 25% to 34% of progression in 20 years. [25] [26] [27] In our study, the follow-up duration was short without progression, but the monoclonal immunoglobulin of one case was missing during follow-up period.
Further study with longer follow-up time was still warrant to examine MGUS.
In conclusion, the prevalence of MGUS in China was similar to that in Mexican Americans, but lower than that in the other Asian country, American whites, American blacks, and Africans, which had a trend of increase with age. Male had higher prevalence of MGUS in China. The most common subtype was IgG. With the gradual increase of life expectancy in China, the screening and regular monitoring of MGUS were relevant.
